Observational, Prospective, Cohort Study of Mpox Infection in Brazil - NETPOX Cohort
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
The study is a prospective cohort that evaluates the clinical and immune-metabolic variables that may be linked to the risk and severity of the infection or even hospitalization or death in patients infected with the Mpox virus in Brazil. The expectation is to include at least 80 patients over six months, with a follow-up of 90 days from inclusion, through contact via decentralized visits.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Men and women aged ≥ 18 years with confirmed MPOX infection.
⁃ (laboratory-confirmed monkeypox infection is defined as determined by PCR, culture, or antigen test obtained from a sample collected from blood, oropharynx, anal or skin lesion within 4 days of randomization)
Locations
Other Locations
Brazil
Hospital Universitário João de Barros Barreto
RECRUITING
Belém
Hospital Naval Marcílio Dias
RECRUITING
Rio De Janeiro
Hospital Israelita Albert Einstein
RECRUITING
São Paulo
Contact Information
Primary
Henrique AR Fonseca, PhD
henrique.fonseca@einstein.br
+5511968308958
Backup
Diogo Moia, PharmD
diogo.moia@einstein.br
Time Frame
Start Date: 2024-07-16
Estimated Completion Date: 2026-12
Participants
Target number of participants: 80
Treatments
Human cases of monkeypox confirmed by PCR
Laboratory-confirmed mpox infection is defined as determined by polymerase chain reaction assay (PCR), culture, or antigen test obtained from a sample collected from blood, oropharynx, anal or skin lesion within 5 days of inclusion.
Related Therapeutic Areas
Sponsors
Leads: Hospital Israelita Albert Einstein
Collaborators: Ministry of Health, Brazil